-Frontline PESA, which is seen as an enabling law for tribal self-governance, is violated brazenly by both the Union government and State governments in the name of development. SINCE October 2012, the Ministry of Rural Development of the United Progressive Alliance (UPA) government has apparently been engaged in an exercise to evolve a "National Land Reforms Policy". Over these months, the Ministry wrote to various State governments, highlighting the importance of...

-The Times of India PABNAWA (HARYANA): It has been over 48 hours since the attack took place. But fear still stalks the dalits of Pabnawa village in Haryana's Kaithal district. The young women from the community have been moved out en masse by their families fearing sexual assault by upper-caste goons. Some were picked up by relatives from nearby villages after desperate SOS calls; others were escorted to safety by their...

-The Hindu   The Supreme Court's reasoning in the Devinder Pal Singh Bhullar case reveals an unfortunate determination to sanction judicial execution because it involved a terrorist offence. If there is one principle that emerges from the judgment of Justice G.S. Singhvi and Justice S.J. Mukhopadhaya, it is that prolonged delay in disposal of a mercy petition, until now considered a possible constitutional limitation on carrying out an execution, will not be...

-The Times of India It is universally recognised that for ensuring people's participation in governance and holistic development, the best instrumentality is local government. So when Parliament passed the 73rd Constitution Amendment Bill on December 23, 1992 to enshrine the essential features of panchayats in the Constitution, this was hailed as historic. But where do our panchayats stand 20 years after becoming institutions of self-government? A big issue before the founders of...

-The Hindu The Supreme Court judgment on Glivec is a blow for a patent regime with a higher threshold of inventiveness On April 1, 2013, the Supreme Court upheld the Intellectual Property Appellate Board's decision to deny patent protection to Novartis's application covering a beta crystalline form of imatinib -the medicine Novartis brands as Glivec, and which is very effective against the form of cancer known as chronic myeloid leukaemia (CML). The...